HomeAboutTechnology & ApplicationsVaccine PipelinePress RoomContact About Ancora Overview Management TeamBoard of DirectorsScientific Advisory Board Barry Buckland, Ph.D. Dr. Buckland currently serves as the CEO of BiologicB, a biotech focused advisory group located in New York City and Philadel...

HomeAboutTechnology & ApplicationsVaccine PipelinePress RoomContact About Ancora Overview Management TeamBoard of DirectorsScientific Advisory Board Peter H. Seeberger Scientific Co-Founder Professor Seeberger is regarded as one of the worlds leading experts in carbohydrate chemistry and biology...

HomeAboutTechnology & ApplicationsVaccine PipelinePress RoomContact Technology & Applications Glycobiology: The Opportunity Overview: Why Synthetic Carbohydrates?Carbohydrate Synthesis Technology Glycobiology: The Opportunity Carbohydrates are the most abundant biomaterials in the natural wo...

HomeAboutTechnology & ApplicationsVaccine PipelinePress RoomContact Press Room Ancora in the News PresentationsPress ReleasesScientific Publications Ancora in the News MIT News Office: Ancora Pharmaceuticals takes top prize in $50K business plan contest bNet: Surface Logix and Ancora Pharmaceuti...

HomeAboutTechnology & ApplicationsVaccine PipelinePress RoomContact About Ancora Overview Management TeamBoard of DirectorsScientific Advisory Board Board of Directors Peter H. SeebergerMisti Ushio, Ph.D.Barry Buckland, Ph.D.Rahul Singhvi, Sc.D., M.B.A Copyright 2008-2013 Ancora Pharmaceuticals ...